Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;9(5):1-7.
doi: 10.1371/journal.pmed.1001220. Epub 2012 May 22.

A prescription for improving drug formulary decision making

Gordon D Schiff  1 , William L Galanter, Jay Duhig, Michael J Koronkowski, Amy E Lodolce, Pam Pontikes, John Busker, Daniel Touchette, Surrey Walton, Bruce L Lambert
Affiliations

A prescription for improving drug formulary decision making

Gordon D Schiff et al. PLoS Med. 2012.

Abstract

Gordon Schiff and colleagues present a new tool and checklist to help formularies make decisions about drug inclusion and to guide rational drug use.

PubMed Disclaimer

Conflict of interest statement

WG received grant funding from Abbott Labs- 2% FTE this year, Consulting with Walgreens (member of P&T Committee, ∼$5,000). JD had a summer student internship with Abbott Laboratories in Regulatory Affairs 2009–2010 7 k (2009) 8 k (2010). SW consulted for Abbott, Genentech, Primus. MK is a Consultant Pharmacist, Pharmacy and Therapeutics Committee, Catalyst Health Solutions, Inc, Rockville, MD. DT received unrestricted grant funding for research from Medco Health Solutions. BL consulted in last 3 years: Abbott (drug name confusion), Transcept. Stock ownership: Pharm I.R., Inc. (my own company, specializing in preventing and detecting drug name confusion errors). Expert witness testimony: Hernandez v. Schering (for Hernandez), Mason v. General Electric Company, et al. (for Mason). Grants received: Abbott (readability of MedGuides), Novartis (development of pharmacoepidemiologic methods), Ortho McNeil (safety of warfarin post orthopedic surgery), AHRQ (Tools for Optimizing Prescribing). Patents received: BLL Consulting, Inc. (related to preventing drug name confusions) Other: Board of Directors (unpaid) for Med-Errs, Inc. (drug name confusion).

Figures

Figure 1
Figure 1. Leveraging formularies for improved prescribing.
Formularies are poised to enhance the quality of drug prescribing decision making beyond that of individual practitioners. By encoding the collective expertise and judgment of a group of physicians and pharmacists who have resources and experience to weigh evidence in context, formularies work in ten ways to help optimize prescribing. In addition to supporting the decision making of individual clinicians, the formulary committee oversees the safe and effective use of drugs in institutions by providing guidance and engaging in ongoing drug utilization review.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Laing R, Waning B, Gray A, Ford N, Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361:1723–1729. - PubMed
    1. Tyler LS, Cole SW, May JR, Millares M, Valentino MA, et al. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Am J Health Syst Pharm. 2008;65:1272–1283. - PubMed
    1. Durán-García E, Santos-Ramos B, Puigventos-Latorre F, Ortega A. Literature review on the structure and operation of Pharmacy and Therapeutics Committees. Int J Clin Pharm. 2011;33:475–483. - PubMed
    1. Tierney M, Manns B. Optimizing the use of prescription drugs in Canada through the Common Drug Review. CMAJ. 2008;178:432–435. - PMC - PubMed
    1. Ouachi Z, Allenet B, Chouchane N, Calop J. Organisation of the formulary decision-making process at the hospital level: review of the international literature. Pharmacien Hospitalier et Clinicien. 2011;46:263–272.

Publication types

Substances